HuR promotes castration-resistant prostate cancer progression by altering ERK5 activation via posttranscriptional regulation of BCAT1.
Hang YouGuojing SongZhizhen XuSaipeng ChenWenhao ShenHeting LiuBingqian DengJun LiGang HuangPublished in: Journal of translational medicine (2024)
We confirmed that the HuR/BCAT1 axis plays a crucial role in CRPC progression and suggest that inhibiting the HuR/BCAT1 axis is a promising therapeutic approach for suppressing CRPC progression.